We are live on ! Find out more
NKGNW

NKGen Biotech, Inc. Warrants
NKGNW

Delisted

NKGNW was delisted on the 4th of March, 2025.

Back to rankings

37 hedge funds and large institutions have $397K invested in NKGen Biotech, Inc. Warrants in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

3% less funds holding

Funds holding: 38 → 37 (-1)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

72% less capital invested

Capital invested by funds: $1.43M → $397K (-$1.03M)

Holders
37
Holders Change
-1
Holders Change %
-2.63%
% of All Funds
0.59%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
6
Closed
1
Calls
$25K
Puts
–
Net Calls
+$25K
Net Calls Change
+$10K

Top Buyers

Rank Fund Capital Flow
1
ETH
Exos TFP Holdings
New York
+$2.65K
2
SCM
Shaolin Capital Management
Florida
+$2.16K
3
FTUS
Flow Traders U.S.
New York
+$1.63K
4
Walleye Capital
Walleye Capital
New York
+$455

Top Sellers

Rank Fund Capital Flow
1
SG
StoneX Group
New York
-$3.73K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$619
3
CH
CVI Holdings
Delaware
-$514
4
GF
Gabelli Funds
New York
-$407
5
AA
AQR Arbitrage
Connecticut
-$333
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Rivernorth Capital Management
Florida
$91.4K – – –
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$25.5K – – –
BNP Paribas Financial Markets
3
BNP Paribas Financial Markets
France
$21K – – –
Balyasny Asset Management
4
Balyasny Asset Management
Illinois
$19.6K – – –
AA
5
AQR Arbitrage
Connecticut
$18K -$333 -2,340 -2%
RCM
6
Radcliffe Capital Management
Pennsylvania
$17.4K – – –
DCM
7
Difesa Capital Management
New York
$16.9K – – –
PC
8
Periscope Capital
Ontario, Canada
$16.8K – – –
Jane Street
9
Jane Street
New York
$14K – – –
6CM
10
683 Capital Management
New York
$14K – – –
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
11
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
$14K – – –
KL
12
KIM LLC
Kansas
$12.9K – – –
PSAMP
13
P. Schoenfeld Asset Management (PSAM)
New York
$11.2K – – –
TCA
14
Taconic Capital Advisors
New York
$9.81K – – –
ETH
15
Exos TFP Holdings
New York
$9.61K +$2.65K +18,600 +37%
SCM
16
Shaolin Capital Management
Florida
$9K +$2.16K +15,171 +30%
PAMP
17
Polar Asset Management Partners
Ontario, Canada
$8.41K – – –
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$7K – – –
MTCM
19
Mint Tower Capital Management
Netherlands
$6K – – –
AIMCA
20
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$5.6K – – –
FBCM
21
Fort Baker Capital Management
California
$5.17K – – –
JFG
22
Jefferies Financial Group
New York
$4.9K – – –
SCM
23
Saba Capital Management
New York
$4.36K – – –
ACM
24
Atalaya Capital Management
New York
$4.2K – – –
CH
25
CVI Holdings
Delaware
$3.7K -$514 -3,614 -12%
1
2

NKGNW Hedge Fund Activity: Q1 2023 in Review

37 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q1 2023, worth a combined $397K — down 72% from $1.43M a quarter earlier.

Fund positioning in NKGNW was balanced in Q1 2023: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 6 trimmed.

The largest buyer was Exos TFP Holdings, adding an estimated $2.65K. The largest seller was StoneX Group, cutting an estimated $3.73K.

  • 37 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q1 2023, down from 38 in Q4 2022.
  • Funds reported $397K of NKGen Biotech, Inc. Warrants stock for Q1 2023, down 72% quarter-over-quarter.
  • 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q1 2023 and 1 closed out, a net change of 0 holders.
  • The largest NKGen Biotech, Inc. Warrants buyer in Q1 2023 was Exos TFP Holdings, an estimated $2.65K added.
  • The largest NKGen Biotech, Inc. Warrants seller in Q1 2023 was StoneX Group, an estimated $3.73K sold.

Based on aggregated 13F filings for Q1 2023.